Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EED | O75530 | 5/20 | 1.00 |
| ▸ | SUZ12 | Q15022 | 5/20 | 1.00 |
| ▸ | EZH2 | Q15910 | 5/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.73 |
| ▸ | EPAS1 | Q99814 | 2/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.73 |
| ▸ | MEN1 | O00255 | 1/20 | 0.73 |
| ▸ | CES2 | O00748 | 1/20 | 0.73 |
| ▸ | APAF1 | O14727 | 1/20 | 0.73 |
| ▸ | TERT | O14746 | 1/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.73 |
| ▸ | LMNA | P02545 | 1/20 | 0.73 |
| ▸ | TP53 | P04637 | 1/20 | 0.73 |
| ▸ | POLB | P06746 | 1/20 | 0.73 |
| ▸ | MAPT | P10636 | 1/20 | 0.73 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.73 |
| ▸ | HPGD | P15428 | 1/20 | 0.73 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.73 |
| ▸ | CES1 | P23141 | 1/20 | 0.73 |
| ▸ | APEX1 | P27695 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tanshinone Iib SCHEMBL14417728 | 1.00 | EED (1.00) | EEDSUZ12EZH2HIF1AEPAS1 | |
| Isotanshinone Iib SCHEMBL30381469 | 0.92 | EED (0.85) | EEDSUZ12EZH2HIF1AEPAS1 | |
| SCHEMBL17663613 | 0.87 | EED (0.77) | EEDSUZ12EZH2HIF1AEPAS1 | |
| SCHEMBL14417696 | 0.86 | EED (0.76) | EEDSUZ12EZH2HIF1AEPAS1 | |
| SCHEMBL16152283 | 0.86 | EED (0.76) | EEDSUZ12EZH2HIF1AEPAS1 | |
| SCHEMBL16152326 | 0.85 | EED (0.78) | EEDSUZ12EZH2HIF1AEPAS1 | |
| Tanshinone Iia SCHEMBL2026738 | 0.84 | EED (1.00) | EEDSUZ12EZH2HIF1AEPAS1 | |
| Methyl Tanshinonate SCHEMBL14417730 | 0.80 | EED (1.00) | EEDSUZ12EZH2HIF1AEPAS1 | |
| Methyl Tanshinonate SCHEMBL16152293 | 0.80 | EED (1.00) | EEDSUZ12EZH2HIF1AEPAS1 | |
| Przewaquinone A SCHEMBL16152272 | 0.78 | IDO1 (1.00) | EEDSUZ12EZH2HIF1AEPAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250170252-A1 | QUINONE PROTECTED FORMS AND CONJUGATES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2025-05-29 | — | — | US | claimed |
| CN-119912517-A | Tanshinone IIB sodium sulfonate derivative and refining method thereof | 上海上药第一生化药业有限公司 | 2025-05-02 | — | — | CN | claimed |
| EP-4532480-A1 | QUINONE PROTECTED FORMS AND CONJUGATES | Cambridge Enterprise Limited (GB) | 2025-04-09 | — | — | EP | claimed |
| CN-118924861-A | Hair-growing and hair-blackening smearing liquid rich in trace elements and proteins | 丁桂芳 | 2024-11-12 | — | — | CN | claimed |
| CN-118021812-A | Nidaminib targeting compositions | 北京睿创康泰医药研究院有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-117924405-A | Refining method of tanshinone IIA sodium sulfonate | 上海上药第一生化药业有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-117899176-A | Chinese medicinal composition for treating coronary heart disease and angina pectoris and preparation method thereof | 陕西步长制药有限公司 | 2024-04-19 | — | — | CN | claimed |
| WO-2023227757-A1 | QUINONE PROTECTED FORMS AND CONJUGATES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2023-11-30 | — | — | WO | claimed |
| CN-115184533-B | LC-MS method for quantitatively detecting golden bell oral liquid | 山东宏济堂制药集团股份有限公司 | 2023-06-20 | — | — | CN | claimed |
| CN-115184533-A | LC-MS method for quantitatively detecting gold scallop oral liquid | 山东宏济堂制药集团股份有限公司 | 2022-10-14 | — | — | CN | claimed |
| CN-114984154-A | Traditional Chinese medicine formula Xinmaitong tablets and preparation method thereof | 唐祖宣 | 2022-09-02 | — | — | CN | claimed |
| CN-121991159-A | Method for selectively synthesizing tanshinone IIB sodium sulfonate and tanshinone IIB | 上海上药第一生化药业有限公司 | 2026-05-08 | — | — | CN | disclosed |
| CN-121991159-A | Method for selectively synthesizing tanshinone IIB sodium sulfonate and tanshinone IIB | 上海上药第一生化药业有限公司 | 2026-05-08 | — | — | CN | disclosed |
| EP-4587011-A1 | COMBINATIONS AND PHARMACEUTICAL COMPOSITIONS COMPRISING A PI3K/AKT/MTOR PATHWAY INHIBITING COMPOUND | Royal Holloway & Bedford New College (GB) | 2025-07-23 | — | — | EP | disclosed |
| CN-120189360-A | Facial mask, preparation method and use method thereof | 北京同仁堂麦尔海生物技术有限公司 | 2025-06-24 | — | — | CN | disclosed |
| EP-2786989-A1 | 2-ALKYL-OR-ARYL-SUBSTITUTED TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF | Hangzhou Bensheng Pharmaceutical Co., Ltd. (CN) | 2014-10-08 | — | — | EP | disclosed |
| EP-2786990-A1 | 2-AMINATED METHYLENE OR 2-ESTERIFIED METHYLENE TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF | Hangzhou Bensheng Pharmaceutical Co., Ltd. (CN) | 2014-10-08 | — | — | EP | disclosed |
| WO-2014138357-A1 | NOVEL TASHINONE DRUGS FOR ALZHEIMER DISEASE | THE UNIVERSITY OF AKRON (US) | 2014-09-12 | — | — | WO | disclosed |
| US-8227426-B2 | Chiral complexes of ascorbic acid with natural antioxidant and anti-inflammatory ketones including aloe, citrus, ginger, and mango for skin and hair care | ISLAND KINETICS INC. (US) | 2012-07-24 | — | — | US | disclosed |
| US-20110059907-A1 | Chiral Complexes of Ascorbic Acid with Natural Antioxidant and Anti-Inflammatory Ketones Including Aloe, Citrus, Ginger, and Mango for Skin and Hair Care | ISLAND KINETICS INC. (US) | 2011-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110059907-A1 | Chiral Complexes of Ascorbic Acid with Natural Antioxidant and Anti-Inflammatory Ketones Including Aloe, Citrus, Ginger, and Mango for Skin and Hair Care | GLA, LPO, PLOD3 | EED 3792/4885SUZ12 4449/4885EZH2 3088/4885 |
| US-20250170252-A1 | QUINONE PROTECTED FORMS AND CONJUGATES | NQO1, SQOR, GSTP1 | EED 116/4885SUZ12 1039/4885EZH2 368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.